학술논문
Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients.
Document Type
Journal Article
Author
Source
Subject
*CANCER relapse
*LUNG cancer
*CLINICAL trial registries
*LUNG surgery
*METASTASIS
*POSTOPERATIVE pain
*NATALIZUMAB
*
*
*
*
*
*
Language
ISSN
1745-6215
Abstract